Clinical efficacy and safety of Ganshuang granules as an adjuvant treatment for chronic hepatitis B liver fibrosis: A protocol for systematic review and meta analysis
Conclusion:
This study will provide scientific evidence to explorer whether GSG are efficacy and safety in treating chronic hepatitis B liver fibrosis.
PROSPERO registration number:
INPLASY202090027
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: China Health | Databases & Libraries | Denmark Health | Hepatitis | Hepatitis B | Internal Medicine | Liver | Study | Urology & Nephrology